Thursday October 7, 10:26 am Eastern Time
M.H. Meyerson & Co., Inc. Restarts Coverage of Colorado MEDTech, Inc. (Nasdaq: CMED) with a 'Buy' Rating
JERSEY CITY, N.J., Oct. 7 /PRNewswire/ -- The following is being issued by M.H. Meyerson & Co., Inc., a member of the National Association of Securities Dealers, CRD number 540:
M.H. Meyerson & Co., Inc., (Nasdaq: MHMY - news) announced coverage has been restarted on Colorado MEDTech, Inc. (Nasdaq: CMED - news), with a ``BUY' rating. A Research Brief is available. The report was prepared by Andrew H. Scott of M.H. Meyerson & Co., Inc., 525 Washington Blvd., Jersey City, New Jersey 07310. For more information, contact Andrew H. Scott at 201-459-9440 or 800-422-4114; web site: mhmeyerson.com.
SOURCE: M.H. Meyerson & Co., Inc. |
